-
The Science of the Total Environment Nov 2022Invasive Alien Species (IAS), i.e. species introduced by humans outside their natural geographic range, may act as host or vectors of pathogens of both human and animal... (Meta-Analysis)
Meta-Analysis
Invasive Alien Species (IAS), i.e. species introduced by humans outside their natural geographic range, may act as host or vectors of pathogens of both human and animal health relevance. Although it has been recognized that IAS should deserve more attention from a public and animal health perspective, data on the pathogens hosted by these species are not systematically collected and this prevents accurate assessments of IAS-specific risks of disease transmission. To support the future development of disease risk assessments, we systematically reviewed the scientific literature related to the pathogens of the eleven mammal species included in the European list of IAS of concern to gain insight in the amount and quality of data available. Data were analyzed to assess the current knowledge on the pathogens harbored by mammal IAS in natural conditions, through the identification of the main factors associated with research intensity on IAS pathogens and with the IAS observed pathogen species richness, the estimation of the true pathogen species richness for each IAS, and a meta-analysis of prevalence for the pathogens of health relevance. While the review confirmed that mammal IAS harbor pathogens of human and animal health relevance such as rabies virus, West Nile Virus, Borrelia burgdorferi and Mycobacterium bovis, results also highlighted strong information gaps and biases in research on IAS pathogens. In addition, the analyses showed an underestimation of the number of pathogens harbored by these species and the existence of high levels of uncertainty in the prevalence of the pathogens of health significance identified. These results highlight the need towards more efforts in making the available information on IAS pathogens accessible and systematically collected in order to provide data for future investigations and risk assessments, as well as the need of relying on alternative sources of information to assess IAS disease risk, like expert opinions.
Topics: Animals; European Union; Introduced Species; Mammals; Risk Assessment; Species Specificity
PubMed: 35863572
DOI: 10.1016/j.scitotenv.2022.157448 -
Multiple Sclerosis and Related Disorders Feb 2022The pathogenesis of neuromyelitis optica spectrum disorder (NMOSD) has been vigorously illustrated, but triggers of the disease remain unclear. Viral infection and...
INTRODUCTION
The pathogenesis of neuromyelitis optica spectrum disorder (NMOSD) has been vigorously illustrated, but triggers of the disease remain unclear. Viral infection and vaccination have been observed to precede certain cases of NMOSD. Amidst the Coronavirus disease 2019 (COVID-19) pandemic, mass vaccination takes place across the globe. We report two cases of newly diagnosed NMOSD following COVID-19 vaccination and systematically review previous reports.
METHOD
Searching of Ovid MEDLINE and EMBASE databases was done using predefined search terms related to NMOSD and vaccination. Duplicates were removed. Newly diagnosed NMOSD cases fulfilling the 2015 International Panel for NMO Diagnosis criteria with symptoms presenting between 2-30 days after vaccination were included. Data on age, sex, comorbidity, vaccine name, type, and dose number, duration from vaccination to symptom onset, clinical phenotype(s), MRI findings, CSF profiles, severity of attack, initial and maintenance treatment, number of relapses after vaccination, and clinical outcomes were extracted using a standardized table and compared.
RESULT
Ten cases of postvaccination NMOSD were identified. Patients aged between 15-46 years old. Nine patients (90%) presented with transverse myelitis and 3 (30%) with optic neuritis. The mean duration from vaccination to clinical onset was 8.2 days (median 9 days). Five patients (50%) tested positive for aquaporin 4 (AQP4) antibody. One patient had a family history of NMOSD. Three-fourths of AQP4-IgG seropositive patients with myelopathy had short transverse myelitis. The reported vaccines included CoronaVac, ChAdOx1 nCoV-19, yellow fever, quadrivalent influenza, H1N1 influenza, quadrivalent human papillomavirus, Japanese encephalitis, rabies, and recombinant hepatitis B virus together with tetanus-diphtheria-pertussis vaccines. All patients received high-dose steroids for initial treatment and 2 received additional therapeutic plasma exchange. Maintenance therapy was given in 4 patients. Five patients (50%) experienced no subsequent relapses within the follow-up period ranging between 3-34 months. Almost all patients returned to baseline functional status.
DISCUSSION
The temporal relationship between vaccination and onset of symptoms suggests that vaccine might be a trigger of NMOSD. Genetic predisposition could be a risk factor for postvaccination NMOSD as there are evidences of family history and presence of an associated HLA allele. The prevalence of short-segment transverse myelitis seems to be higher than in typical cases of NMOSD, but the natural history is otherwise similar. All patients received acute treatment with high-dose corticosteroids, most with excellent response. Long-term immunomodulation therapy should be initiated for relapse prevention. Limitations of this study are lack of some relevant data, precision of temporal relationship, and the small number of reports.
CONCLUSION
Postvaccination NMOSD is a rare condition that can occur with various types of vaccines. The short temporal relationship between vaccination and onset of NMOSD and the history of NMOSD in one patient's sibling indicate that vaccine might be a trigger for genetically predisposed individuals.
Topics: Adolescent; Adult; Humans; Middle Aged; Young Adult; Aquaporin 4; Autoantibodies; ChAdOx1 nCoV-19; COVID-19; COVID-19 Vaccines; Influenza A Virus, H1N1 Subtype; Neoplasm Recurrence, Local; Neuromyelitis Optica; SARS-CoV-2; Vaccination
PubMed: 35216789
DOI: 10.1016/j.msard.2021.103414